Steve Lundy, President, CEO at AspenBio Pharma, Inc. (APPY), bought 4,000 shares at $1.93 ($8K) on 2012-06-29, disclosed to the SEC on 2012-07-02.
Open-market purchase of $8k APPY by President, CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.